GlassScriptPhysician profile
Carol Anne Livoti
NPI 1023156163
$1,433.81
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $384 · 2021: $376 · 2022: $449.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $340.91 | 2020-2022 | |
| Pfizer INC. | $306.62 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $115.30 | 2019-2020 | |
| Hologic Sales and Service, LLC | $86.59 | 2020-2022 | |
| Organon LLC | $72.84 | 2022 | |
| Therapeuticsmd, INC. | $68.90 | 2020-2021 | |
| Avion Pharmaceuticals | $66.58 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $53.82 | 2019 | |
| Scynexis, INC. | $48.81 | 2022 | |
| Mayne Pharma Commercial LLC | $43.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.28 | 2020 | |
| Agile Therapeutics, INC. | $37.44 | 2022 | |
| Virtus Pharmaceuticals LLC | $29.56 | 2021 | |
| Myovant Sciences INC. | $26.14 | 2022 | |
| Evofem Biosciences, INC. | $21.23 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $19.37 | 2019 | |
| Ascend Therapeutics US, LLC | $16.00 | 2019 | |
| Allergan, INC. | $15.97 | 2019 | |
| Becton, Dickinson and Company | $15.41 | 2021 | |
| Lupin INC. | $11.02 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Livoti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.